Engineers Gate Manager’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Engineers Gate Manager’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,033	Closed	-$40K	–	2431
2021 Q4	$40K	Buy	+3,033	New	+$50.2K	﹤0.01%	1896
2020 Q3	–	Sell	-3,050	Closed	-$183K	–	2052
2020 Q2	$183K	Buy	3,050 +1,750	+135%	+$160K	0.01%	1470
2020 Q1	$98K	Buy	+1,300	New	+$150K	0.01%	1417

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Engineers Gate Manager's ORTX Position: Q1 2022 in Review

Engineers Gate Manager sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2022, closing a stake of 3,033 shares — an estimated $40K sold.

Engineers Gate Manager first reported a position in ORTX in Q1 2020 and held it in 3 quarters. The position peaked at $183K in Q2 2020. 61 funds tracked by Wall St. Rank hold ORTX as of Q1 2022.

Engineers Gate Manager reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Engineers Gate Manager sold 3,033 Orchard Therapeutics plc American Depositary Shares shares in Q1 2022, an estimated $40K.
Engineers Gate Manager first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2020 and held it in 3 quarters.
Engineers Gate Manager's Orchard Therapeutics plc American Depositary Shares position peaked at $183K in Q2 2020.
61 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2022.

Based on Engineers Gate Manager's 13F filing for Q1 2022, filed 16 May 2022.